NXL
What one share of Nexalin Technology holds
Electromedical and Electrotherapeutic Apparatus
Nexalin is headquartered, and maintains its base of management and operations, in Houston, Texas. We design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.
Nexalin Technology’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.01 |
|---|---|
| Profit | −$0.46 |
| Cash and investments | $0.05 |
| Book value | $0.07 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $0.24 | −$0.30 | — | −$0.40 | — | $0.75 |
| 2023 | $0.02 | −$0.63 | — | −$0.52 | — | $0.43 |
| 2024 | $0.02 | −$0.83 | — | −$0.43 | — | $0.28 |
| 2025 | $0.02 | −$0.50 | — | −$0.30 | — | $0.20 |